Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Therapies
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le mercredi 8 janvier 2020
Doi : 10.1016/j.therap.2019.12.007
Received : 18 October 2019 ;  accepted : 12 December 2019
Use of triptans during pregnancy? With caution!
 

Isabelle Lacroix a, , Caroline Hurault-Delarue a, Delphine Viard b, Bruno Revol c, Lemya Chaalel a, Christine Damase-Michel a
a Service de pharmacologie médicale et clinique, centre régional de pharmacovigilance, faculté de médecine, Inserm 1027, 31000 Toulouse, France 
b Centre régional de pharmacovigilance, hôpital de Cimiez, 06003 Nice, France 
c Centre Régional de Pharmacovigilance, CHU Grenoble, Grenoble, France 

Corresponding author. Service de pharmacologie médicale et clinique, CHU de Toulouse, faculté de médecine, 37, allées Jules-Guesde, 31000 Toulouse, France.Service de pharmacologie médicale et clinique, CHU de Toulouse, faculté de médecine37, allées Jules-GuesdeToulouse31000France
Summary

We report cases, registered in the French national pharmacovigilance database, of fetal death and intrauterine growth retardation in women exposed to triptans during pregnancy. Triptans have vasoconstrictive properties and we wonder about their responsibility for these side effects. The use of triptans and other drugs exhibiting vasoconstrictive properties in pregnant women requires a careful benefits/risks evaluation.

The full text of this article is available in PDF format.

Keywords : Drugs, Triptans, Pregnancy, Fetal death, Intra-uterine growth retardation




© 2019  Société française de pharmacologie et de thérapeutique@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline